Nykode Therapeutics AS (OSL:NYKD)

Nykode Therapeutics AS Revenue

Nykode Therapeutics AS had revenue of $118.00K USD in the quarter ending September 30, 2025, a decrease of -82.26%. This brings the company's revenue in the last twelve months to $7.35M, up 68.10% year-over-year. In the year 2024, Nykode Therapeutics AS had annual revenue of $9.16M, down -31.26%.

• Revenue (ttm): $7.35M
• Revenue Growth: +68.10%
• P/S Ratio: 9.79
• Revenue / Employee: $54.01K
• Employees: 136
• Market Cap: 718.40M NOK

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.16M	-4.17M	-31.26%
Dec 31, 2023	13.32M	4.29M	47.56%
Dec 31, 2022	9.03M	-26.74M	-74.76%
Dec 31, 2021	35.77M	-179.93M	-83.42%
Dec 31, 2020	215.70M	214.28M	15,175.85%